Cargando…

Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer

Developing combination therapy for castrate-resistant prostate cancer (CRPC) may require exploiting new drug targets outside androgen receptor and PI3K / AKT / mTOR signal transduction pathways implicated in prostate cancer (PCa) progression. One such possible new target is YWHAZ of the 14-3-3 prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Root, Alex, Beizaei, Azadeh, Ebhardt, H. Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208026/ https://www.ncbi.nlm.nih.gov/pubmed/30382885 http://dx.doi.org/10.1186/s12943-018-0905-y

Ejemplares similares

A two‐drug combination simulation study for metastatic castrate resistant prostate cancer
por: Root, Alex, et al.
Publicado: (2018)

Applications of targeted proteomics in systems biology and translational medicine
por: Ebhardt, H. Alexander, et al.
Publicado: (2015)

Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer
por: Ebhardt, H. Alexander, et al.
Publicado: (2018)

The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
por: Touzeau, C, et al.
Publicado: (2014)

MMSET is the key molecular target in t(4;14) myeloma
por: Mirabella, F, et al.
Publicado: (2013)

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population
por: Wei, Han-Min, et al.
Publicado: (2015)

3B circumscribed masses: to assess or not to assess?
por: Bonetti, F, et al.
Publicado: (2008)

Reply: 3B circumscribed masses: to assess or not to assess?
por: Farshid, G, et al.
Publicado: (2008)

An 18.3-Mb Duplication on Chromosome 14q With Multiple Cardiac Anomalies and Clubfoot Was Identified by Microarray Analysis
por: Yoon, Jihoon G., et al.
Publicado: (2016)

Cyr61: a potential therapeutic target for prostate cancer
por: Lin, Chang-Ming, et al.
Publicado: (2014)

Structural basis of the activation of metabotropic glutamate receptor 3
por: Fang, Wei, et al.
Publicado: (2022)

Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
por: Shah, Kinjal, et al.
Publicado: (2018)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
por: Liu, Xinyu, et al.
Publicado: (2018)

Structural insights into the TRIM family of ubiquitin E3 ligases
por: Li, Yang, et al.
Publicado: (2014)

Significance of t (8: 14) in CLL?
por: Lakshmaiah, K. C., et al.
Publicado: (2010)

Assessment of AI-Based Protein Structure Prediction for the NLRP3 Target
por: Yin, Jian, et al.
Publicado: (2022)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2018)

Selectively targeting FLT3-ITD mutants over FLT3- wt by a novel inhibitor for acute myeloid leukemia
por: Wang, Aoli, et al.
Publicado: (2020)

Structural insights into the functional roles of 14-3-3 proteins
por: Obsilova, Veronika, et al.
Publicado: (2022)

ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
por: Freeman, Michael R., et al.
Publicado: (2019)

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice
por: Patel, S, et al.
Publicado: (2015)

Protein intrinsic disorder and network connectivity. The case of 14-3-3 proteins
por: Uhart, Marina, et al.
Publicado: (2014)

PorB2/3 Protein Hybrid in Neisseria meningitidis
por: Abad, Raquel, et al.
Publicado: (2008)

Re: Preliminary assessment of neck circumference in benign prostatic hyperplasia in patients with metabolic syndrome
por: Besiroglu, Huseyin, et al.
Publicado: (2017)

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas
por: Verbeke, S., et al.
Publicado: (2021)

Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
por: Yano, Akihiro, et al.
Publicado: (2019)

Galectin‐3 in venous thrombosis: A possible new target for improved patient care
por: Flaherty, Melanie M., et al.
Publicado: (2018)

A rare presentation of primary lateral ventricle H3 K27-altered diffuse midline glioma in a 14-year-old girl: a case description
por: Zhao, Baolian, et al.
Publicado: (2022)

Crystal structures of two phytohormone signal-transducing α/β hydrolases: karrikin-signaling KAI2 and strigolactone-signaling DWARF14
por: Zhao, Li-Hua, et al.
Publicado: (2013)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Confocal 3D DNA Cytometry: Assessment of Required Coefficient of Variation By Computer Simulation
por: Garini, Yuval
Publicado: (2006)

Confocal 3D DNA Cytometry: Assessment of Required Coefficient of Variation by Computer Simulation
por: Ploeger, Lennert S., et al.
Publicado: (2006)

NMR assignment of the protein nsp3a from SARS-CoV
por: Serrano, P., et al.
Publicado: (2006)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

Prostatic abscess
por: Kumar Baishya, Ramen, et al.
Publicado: (2010)

Facile and diastereoselective arylation of the privileged 1,4-dihydroisoquinolin-3(2H)-one scaffold
por: Dar’in, Dmitry, et al.
Publicado: (2022)

Controllability of protein-protein interaction phosphorylation-based networks: Participation of the hub 14-3-3 protein family
por: Uhart, Marina, et al.
Publicado: (2016)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Uptake of prostate-specific membrane antigen-targeted (18)F-DCFPyL in avascular necrosis of the femoral head
por: Safali, Selim, et al.
Publicado: (2020)

Resilience after 3/11: structural brain changes 1 year after the Japanese earthquake
por: Sekiguchi, A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v8e42vhjh5foq3bm4kkksd1s1q